Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-03
DOI
10.1038/s41587-022-01540-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The promise of stem cell-derived islet replacement therapy
- (2021) Douglas Melton DIABETOLOGIA
- The SIRPα–CD47 immune checkpoint in NK cells
- (2021) Tobias Deuse et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity of CAR T cells in cancer therapy
- (2021) Dimitrios L. Wagner et al. Nature Reviews Clinical Oncology
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
- (2021) Bo Wang et al. Nature Biomedical Engineering
- Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
- (2021) Leila Peraro et al. MOLECULAR THERAPY
- Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
- (2021) Tobias Deuse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes
- (2021) Adam Ramzy et al. Cell Stem Cell
- Immune-evasive human islet-like organoids ameliorate diabetes
- (2020) Eiji Yoshihara et al. NATURE
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
- (2019) Tobias Deuse et al. NATURE BIOTECHNOLOGY
- Antibody-Mediated Rejection of Solid-Organ Allografts
- (2018) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies
- (2017) Nicole M. Valenzuela et al. JOURNAL OF CLINICAL INVESTIGATION
- Regenerative therapy for hypothyroidism: Mechanisms and possibilities
- (2017) Anthony N. Hollenberg et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
- (2017) Stanley C. Jordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- Advances in islet encapsulation technologies
- (2016) Tejal Desai et al. NATURE REVIEWS DRUG DISCOVERY
- Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
- (2015) Jay S. Skyler et al. DIABETES CARE
- Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1
- (2015) Philippe Menasché et al. EUROPEAN HEART JOURNAL
- Humanized Medium (h7H) Allows Long-Term Primary Follicular Thyroid Cultures From Human Normal Thyroid, Benign Neoplasm, and Cancer
- (2013) Susana B. Bravo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies
- (2013) Marie-Luise Arnold et al. TRANSPLANT INTERNATIONAL
- Autoimmune thyroid disease
- (2011) Nikolaos Stathatos et al. CURRENT OPINION IN RHEUMATOLOGY
- Pretransplant IgG Subclasses of Donor-Specific Human Leukocyte Antigen Antibodies and Development of Antibody-Mediated Rejection
- (2011) Gideon Hönger et al. TRANSPLANTATION
- Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
- (2010) Michael C. Jensen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells
- (2010) C. H. J. Lamers et al. BLOOD
- Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I–related chain A and are significantly associated with development of chronic rejection after human lung transplantation
- (2010) Nataraju Angaswamy et al. HUMAN IMMUNOLOGY
- The HLA genomic loci map: expression, interaction, diversity and disease
- (2009) Takashi Shiina et al. JOURNAL OF HUMAN GENETICS
- Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
- (2008) B. G. Till et al. BLOOD
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Antithyroperoxidase Antibody-Dependent Cytotoxicity in Autoimmune Thyroid Disease
- (2007) Sandra A. Rebuffat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now